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Prostatic Carcinoma with emphasis on Gleason’s 
Grading: an Institution based Experience 
Z. Ahmed,S. Muzaffar  ( Department of Pathology, The Aga Khan University Hospital, Karachi. ) 
 
Abstract  
Objective:To grade prostatic carcinomas according to the Gleason’s Grading System and 
see whether the frequency of incidental carcinoma is significant. 
Method:Retrospective study of all consecutive cases of prostatic adenocarcinoma 
diagnosed at Aga Khan University Hospital (AKUH) between January 1st, 1996 and 
December 31st, 1999. 
Setting:The histopathology section of AKUH, Karachi. 
Observation:Prostatic adenocarcinomas comprised 14.2% of all prostate specimens. 
There were 3 types of specimens i.e. transurethral resection, suprapubic prostatectomies 
and core bIopsies. The mean age was 72.1 years; 68.1% patients were 65 years or older. 
The majority of the tumours were moderately differentiated (Gleason’s scores 5,6 or 7). 
Grading was not possible in most core biopsies. The frequency of Incidental carcinoma 
was 31.4%. 
Conclusion:Majority of tumours were moderate to poorly differentiated, Indicating that 
prostatic adenocarcinoma Is an aggressive disease. The frequency of incidental 
carcinoma was also high emphasizing need for more aggressive prostatic evaluation in 
the vulnerable age group (JPMA 52:54;2002). 
Introduction  
World wide, carcinoma of the prostate is the most common cancer and the second leading 
cause of cancer death in males i.e. 10%1, The age-adjusted incidence is on an increase in 
most countries. Hormonal factors (androgens) are believed to play a role in the 
development of prostate cancer2. Various Pakistani studies on spectrum of malignant 
tumours in males have given varying results on the frequency of prostate cancer in the 
country3-6. According to first report from Karachi Cancer Registry, prostatic 
adenocarcinoma ranks at number six among cancers in males in Pakistan7. Most cases of 
prostate cancer are seen in men above age 50 years. The incidence of latent’prostatic 
cancer (i.e. when a microscopic focus of cancer is discovered as an incidental finding, 
either at post mortem examination or in a surgical specimen removed for other reasons 
e.g. nodular hyperplasia) is even higher8. According to Western data, carcinoma of 
prostate is more common in USA and other Western countries as compared to Asia where 
rates are very low9. There is a tendency for the incidence of prostate cancer to increase in 
populations with low incidence rate when they migrate to a high incidence locale, 
showing that environmental influences play a role in the development of this disease1. 
Approximately 70% cancers arise in the peripheral zone of the prostate - whether 
posteriorly, laterally or anteriorly and tend to spare the periurethral region except in late 
stages10. The Gleason’s grading system is currently the preferred system, for the grading 
of these tumours11,12. It has shown a remarkable correlation with mortality rates. Patients 
with a score of 2 to 4 do not develop aggressive disease whereas most patients with a 
score of 8 to 10 die of it13. A reasonably good correlation exists between the tumour 
grade determined by biopsy and that determined by prostatectomy4. 
The aim of our study was to determine the grading of prostatic adenocarcinoma in our 
practice according to Gleason’s grading system and to see whether the frequency of 
incidental carcinoma was significant. 
Materials and Methods  
The study was conducted in the section of Histopathology, Aga Khan University Hospital 
(AKUH). All cases of prostatic adenocarcinoma diagnosed between January 1st, 1996 
and December 31st, 1999 were included in the study. The types of specimen included 
transurethral resection (T.U.R.) specimens, transabdominal suprapubic resection 
specimens and core biopsy specimens. These cases included AKUH inpatients and 
specimens received from all over Pakistan via various AKUH collection points. All 
specimens were fixed in10% buffered formalin, routinely processed under standardized 
conditions for paraffin embedding, sectioned and finally stained with Hematoxylin and 
Eosin using standard procedures. The tumours were graded according to the Gleason’s 
grading system11. 
Results  
A total number of 2708 prostate specimens were received during the study period and the 
number df primary adenocarcinomas was 385 (14.2%). Of these, 146 (37.9%) were 
transurethral (T.U.R.) specimens, 139 (36.1%) were transabdominal suprapubic resection 
specimens and 100 (25.9%) were core biopsy specimens. The age range was 42-94 years 
with a mean age of 72.1 years and median age of 70 years. Two hundred and sixty two 
patients (68.0%) were 65 years and above. In 66 cases (17.1%), no grading was possible. 
Most of these cases were core biopsy specimens. Of the 319 cases in which grading was 
performed, Gleason’s scoring was possible in 267 cases (83.7%) (Table 1). 
 In 52 cases (13.5%), Gleason’s scoring was not possible. These cases were however, 
simply graded as well, moderately or poorly differentiated. The majority of tumours had 
Gleason’s score of 5,6 or 7 (i.e. moderately differentiated) (Table 2). 
 
In 230 cases (59.7%), clinical suspicion of carcinoma was raised. In case of AKUH 
inpatients, the clinical suspicion was based on digital rectal examination, transrectal 
ultrasound and serum PSA levels. In specimens received from outside AKUH and 
especially in specimens received from outside Karachi, mostly clinical suspicion was 
based on digital examination or urinary symptoms such as weak urine stream, dribbling 
etc. Transrectal ultrasound and serum PSA levels were performed in very few cases. In 
121 cases (3 1.4%), clinical impression was benign and the carcinoma was an incidental 
finding. In 34 cases (8.8%), no clinical details were provided. 
Discussion  
According to Western Studies, adenocarcinoma of the prostate is much less common in 
Asia as compared to the West9. Results of various Pakistani studies3-6 are inconclusive. 
According to the initial results from the Karachi Cancer registry7, prostatic 
adenocarcinoma ranks at number six among malignant tumours in males. In the West, 
with the widespread use of serum PSA testing, the number of nonpalpable cancers 
diagnosed by needle biopsy has markedly increased15. In our country also, the use of 
needle biopsy as a diagnostic modality is increasing. The usual practice is to send six core 
biopsy specimens in separate containers, i.e., from right apex, right mid, right base and 
left apex, left mid and left base of the prostate (Sextant biopsies). Thin14  gauge trucut 
needles are used. The biopsy is performed by the transrectal route with or without 
ultrasound guidance. However, the largest number of specimens are still T.U.R. and 
suprapubic resection, which are used as both diagnostic and therapeutic modalities. 
The selection of T.U.R. vs suprapubic resection is the surgeon’s prerogative. Curative 
radical prostatectomy is still very limited. In our study the mean age of patients was 
72.1% years and more than 68% patients were 65 years or above. This corresponds to the 
Western data1. 
As shown in Table 1, Gleason’s scoring was possible in 267 out of the total 385 cases 
(69.3%); in over 90% of T.U.R. specimens and almost 80% of suprapubic resection 
specimens. But it was possible in 23% of needle biopsy specimens. In another 52 cases 
(13.5%), Gleason’s grading was not possible but these cases were classified as well, 
moderately or poorly differentiated. In 64 cases (17.2%), no grading was possible. The 
reasons for inability to grade lesions included the small size of specimen (in core 
biopsies) or limited foci of adenocarcinomas (in suprapubic + T.U.R. specimens). In the 
West also, false negative rate with core biopsies is approximately 25% (from 12 to 28%) 
due to limited amount of tissue present16,17. As indicated in the results, incidence of latent 
prostatic cancer was high (3 1.4%). In these cases, surgeon was suspecting benign 
nodular hyperplasia and carcinoma was instead discovered on biopsy. Tumour may be 
clinically unsuspected because: 
(a) there may be only small amounts of scattered tumour, (b) the tumour may be 
predominantly centrally or anteriorly located, (c) the tumour may diffusely infiltrate 
prostate without resulting in induration or a clinically detectable nodule or (d) the tumour 
may be well defined and peripherally located but still not palpable for reasons 
unknown18. It is imperative that in any case of carcinoma prostate, digital rectal 
examination must be supplemented by transrectal ultrasound and serum PSA levels. This 
may help in significantly reducing the magnitude of incidental carcinoma found later. 
The large majority of cases in which Gleason’s grading was performed were moderate to 
poorly differentiated (Table 2). This shows that the large majority of prostatic 
adenocarcinomas in our country behave aggressively as the Gleason’s grading system 
shows a remarkable correlation with mortality rates13. As shown in the results, no cases 
of PIN (Prostatic Intraepithelial Neoplasia) were diagnosed. The main reason is that, as in 
other organs we see mostly advanced disease in our country. Yet, now that the histologic 
criteria for PIN are well established19, biopsies should be more critically evaluated so that 
cases of PIN are not missed. 
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